Testosterone Replacement Therapy Products Liability Litigation News

A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. U.S. …

A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc. that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. U.S. District Judge Matthew Kennelly …